GENTIAN Probability of Target Price Finishing Above 52.0

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;padding-top: 25px;;'>GD</div>
GENT-ME -- Norway Stock  

NOK 53.00  4.00  7.02%

GENTIAN DIAGNOSTIC probability of target price tool provides mechanism to make assumptions about upside and downside potential of GENTIAN DIAGNOSTIC performance during a given time horizon utilizing its historical volatility.

Search Price Probability

 
Refresh
Please specify GENTIAN DIAGNOSTIC time horizon, a valid symbol (red box) and a target price (blue box) you would like GENTIAN DIAGNOSTIC odds to be computed. Please check GENTIAN DIAGNOSTIC Backtesting, GENTIAN DIAGNOSTIC Valuation, GENTIAN DIAGNOSTIC Correlation, GENTIAN DIAGNOSTIC Hype Analysis, GENTIAN DIAGNOSTIC Volatility, GENTIAN DIAGNOSTIC History as well as GENTIAN DIAGNOSTIC Performance.
Apply Odds

GENTIAN DIAGNOSTIC Target Price Odds to finish below 52.0

Current PriceHorizonTarget PriceOdds to drop to  52.00  or more in 30 days
 53.00 30 days 52.00 
about 77.05
Based on a normal probability distribution, the odds of GENTIAN DIAGNOSTIC to drop to  52.00  or more in 30 days from now is about 77.05 (This GENTIAN DIAGNOSTIC probability density function shows the probability of GENTIAN DIAGNOSTIC Stock to fall within a particular range of prices over 30 days) . Probability of GENTIAN DIAGNOSTIC price to stay between  52.00  and its current price of 53.0 at the end of the 30-day period is about 7.47 .
Assuming the 30 trading days horizon, GENTIAN DIAGNOSTIC has a beta of -0.1801. This usually indicates as returns on benchmark increase, returns on holding GENTIAN DIAGNOSTIC are expected to decrease at a much lower rate. During the bear market, however, GENTIAN DIAGNOSTIC is likely to outperform the market. Additionally The company has an alpha of 0.4239, implying that it can generate a 0.42 percent excess return over DOW after adjusting for the inherited market risk (beta).
 GENTIAN DIAGNOSTIC Price Density 
      Price 
α
Alpha over DOW
=0.42
β
Beta against DOW=-0.18
σ
Overall volatility
=3.61
Ir
Information ratio =0.07

GENTIAN DIAGNOSTIC Alerts and Suggestions

GENTIAN DIAGNOSTIC has very high historical volatility over the last 30 days
The company reported revenue of 62.45 M. Net Loss for the year was (38.12 M) with profit before overhead, payroll, taxes, and interest of 29.93 M.
The company has accumulated about 161.07 M in cash with (25.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.46.
Roughly 49.0% of the company shares are held by company insiders

GENTIAN DIAGNOSTICPrice Density Drivers

Float Shares6.77M
Average Daily Volume Last 10 Day8.75k
Average Daily Volume In Three Month7.89k
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page